Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search)
reported case » reported cases (Expand Search), reported use (Expand Search), reported race (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search)
reported case » reported cases (Expand Search), reported use (Expand Search), reported race (Expand Search)
-
441
-
442
-
443
-
444
-
445
-
446
-
447
Supplementary Material for: Exclusively macular phenotype of non-syndromic MFSD8-related disease: A Case Report
Published 2025“…Introduction: The purpose of this report is to highlight the clinical phenotype and imaging findings in a patient with an exclusively macular phenotype of non-syndromic MFSD8-related disease, and to provide clinical evidence for pathogenicity reclassification of a variant of uncertain significance (VUS) MFSD8 c.291G>C (p.Trp97Cys). …”
-
448
-
449
-
450
-
451
-
452
-
453
-
454
NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission.
Published 2025“…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P < 0.001). …”
-
455
-
456
-
457
-
458
-
459
Data Sheet 1_Case Report: A case of first-line treatment for rare ROS1 fusion mutation lung adenocarcinoma with entrectinib.pdf
Published 2025“…At least 55 partner genes have been identified that can fuse with ROS1.Herein, we report a case of a lung adenocarcinoma patient harboring a rare ROS1 fusion mutation with brain metastasis, who achieved good control of both lung and intracranial lesions after treatment with Entrectinib. …”
-
460